DocSym
β
Searchsearch
Search
(P72.0) Neonatal goitre, not elsewhere classified
More details coming soon
27 930 in individuals diagnosis neonatal goitre, not elsewhere classified confirmed
Diagnosis neonatal goitre, not elsewhere classified is diagnosed Men are 7.30% more likely than Women
14 985
Men receive the diagnosis neonatal goitre, not elsewhere classified
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
12 945
Women receive the diagnosis neonatal goitre, not elsewhere classified
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease neonatal goitre, not elsewhere classified - Men and Women aged 0
In Men diagnosis is most often set at age 0-5
Less common in men the disease occurs at Age 5-95+Less common in women the disease occurs at Age 0-19, 25-95+
In Women diagnosis is most often set at age 0-1, 20-24
Disease Features neonatal goitre, not elsewhere classified
Absence or low individual and public risk
Neonatal goitre, not elsewhere classified - what does this mean
Neonatal goitre, not elsewhere classified, is a condition in which an infant is born with an enlarged thyroid gland. it is caused by an underactive thyroid gland in the infant, which can be caused by a number of factors, including genetic defects, iodine deficiency, or maternal thyroid-related conditions.
What happens during the disease - neonatal goitre, not elsewhere classified
Neonatal goitre is caused by an inadequate supply of thyroid hormones during the fetal development stage, resulting in an enlarged thyroid gland. this is due to a lack of maternal thyroid hormones crossing the placenta, or an inherited genetic disorder that affects the thyroid gland's ability to produce hormones. in some cases, the cause is unknown.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination of the newborn
- Thyroid function tests
- Thyroid imaging studies
- Thyroid hormone level tests
- Thyroid antibody tests
- Genetic testing
- Ultrasound of the neck
- Radioactive iodine uptake test
Treatment and Medical Assistance
Main goal of the treatment: To reduce the size of the goitre and improve the functioning of the thyroid.
- Administering thyroid hormone replacement therapy
- Monitoring thyroid function tests
- Monitoring levels of calcium and other minerals in the blood
- Monitoring the size of the goitre
- Providing dietary advice to reduce the goitre size
- Providing psychological support to the patient and their family
- Providing lifestyle advice to reduce stress and improve overall health
- Referring the patient to a specialist if necessary
10 Days of Hospitalization Required
37 Hours Required for Outpatient Treatment
Neonatal goitre, not elsewhere classified - Prevention
Neonatal goitre, not elsewhere classified, can be prevented by ensuring that pregnant women have adequate iodine intake, either through a balanced diet or through supplementation. additionally, pregnant women should be tested for thyroid abnormalities, and if present, treated appropriately.